insight and Innovation

The Critical Role of PSPs in Cell and Gene Therapy Launches

February 2024

Apodi’s latest article examines the critical components of effective PSPs that can support cell and gene therapy launches.

Patient Support Programmes – the key trends of 2023

January 2024

Pharmaceutical companies are increasingly recognising the benefits of Patient Support Programmes in enhancing patient outcomes and improving access to their medicines.

Patients Are Waiting

January 2024

With over 7.7 million patients currently sat on an NHS waiting list, pharmaceutical companies are increasingly turning to innovative Patient Support Programmes to ensure patients can benefit from their medicines..

Dedicated Specialist Nurse Teams

January 2024

The deployment of a Dedicated Specialist Nurse Team can transform a pharmaceutical company’s proposition to the NHS – not only is it providing an effective medicine, but they are also helping the NHS treat and care for those patients that the medicine was designed to help.

Is It Time For A New Homecare Model?

December 2023

Commoditisation and procurement processes within the homecare market is causing dissatisfaction among patients and the NHS.

Digital & Virtual Care Driving Patient Access

November 2023

The access to virtual care is making a dramatic improvement to patient care and support in a number of key therapy areas such as GI and respiratory. Learn more here.

Competition is Rising in Rare Diseases

November 2023

As the rare disease sector experiences significant advancements in drug and therapy development, the pharmaceutical landscape is witnessing a rise in competition.

Engagement with MDTs

November 2023

MDTs can play an important role in determining the appropriate treatment of patients within more complex care pathways. Given this, pharmaceutical companies need to determine the most effective engagement strategies with MDTs to meet their objectives of driving access to their medicines, improve patient outcomes and experiences, and to provide the NHS with much needed help.

Transitioning to Biosimilars – Lessons From Around the World

October 2023

Apodi’s latest innovation and insight piece explores the experiences of healthcare providers including rheumatologists, rheumatology nurses and pharmacists as they transition patients to a biosimilar.

Innovation in Homecare: A Plea From Pharmacy

February 2023

Pharmacists and Clinicians have different needs and priorities when it comes to homecare services for their patients. Find out exactly what these are as we summarise the outputs from Apodi’s latest Roundtable discussion titled Innovation in Homecare.

Accelerating the Patient Programme Initiation Phase

February 2023

A key determinant of success when implementing Patient Programmes is the speed of the initiation phase. More specifically, the Trust Engagement and Patient Access processes. Find out more in February’s Market Insight.

The Importance of Project Management Software

January 2023

Workflow management software can save the average employee 498 hours per year. To find out how, read Apodi’s latest market insight.

Help the NHS Now: Keeping Innovation Simple and Effective

January 2023

Innovative new relationships can drive dramatic results. Patient Programmes even at their most basic level can transform the lives of those working in the NHS and their patients.

Market Insight: Customise Patient Programmes

December 2022

Market research is a fundamental tool when developing Patient Programmes. The intel gathered enables strategists to customise their Patient Programmes to meet the needs of NHS Trusts. Read more here as Apodi delve into the current NHS climate of waiting lists and capacity issues.

The Link Between Innovation: Simplicity: Speed

December 2022

An estimated 117,000 patients died last year waiting for care in the NHS according to a recent article in the Evening Standard. Complex and bureaucratic implementation processes can have a devastating impact on patients’ lives. Find out more in Apodi’s latest article that discusses the link between innovation, simplicity, and speed.

Keeping Patients Out of Hospitals

November 2022

According to NHS England, 7.1 million people are currently waiting to be seen by the NHS. Our latest Market Insight explores 3 ways to keep patients out of hospitals and how Pharmaceutical Companies can assist to reduce the burden on the NHS whilst also driving access to their medicines.

Reduce Waiting Lists and Drive your Agenda

November 2022

The Pharma industry can play a massive role in the promotion and support of the NHS Innovation Agenda to drive down patient waiting lists. Find out the latest innovations and initiatives that are hitting the marketplace.

Market Insight: NHS Waiting Lists

October 2022

Read our Market Insight one pager that explores the issue of waiting lists within the NHS and the access strategies that enable pharmaceutical companies to drive access to their medicines.

Innovation In Homecare

October 2022

In a complex and everchanging healthcare environment, we look at ideas for innovations in the delivery of homecare services which drive differentiation and value to patients and the NHS.

Resources / Insight & Innovation

The Critical Role of PSPs in Cell and Gene Therapy Launches

Patient Support Programmes – the key trends of 2023

Patients Are Waiting

Dedicated Specialist Nurse Teams

Is It Time For A New Homecare Model?

Digital & Virtual Care Driving Patient Access

Competition is Rising in Rare Diseases

Engagement with MDTs

Transitioning to Biosimilars – Lessons From Around the World

Innovation in Homecare: A Plea From Pharmacy

Accelerating the Patient Programme Initiation Phase

The Importance of Project Management Software

Help the NHS Now: Keeping Innovation Simple and Effective

Market Insight: Customise Patient Programmes

The Link Between Innovation: Simplicity: Speed

Keeping Patients Out of Hospitals

Reduce Waiting Lists and Drive your Agenda

Market Insight: NHS Waiting Lists

Innovation In Homecare

Recruitment

HR & Development

HCPs & Patients

Contact